Insider · CIK 0001641073
Laith L Yaldoo
Files at ZIVO (Zivo Bioscience, Inc.). First filing Oct 17, 2024, latest Mar 3, 2026.
In brief
Laith L Yaldoo files SEC Form 4 as director and 10% owner at ZIVO (Zivo Bioscience, Inc.). Since Oct 17, 2024, Laith L Yaldoo has reported 9 open-market buys worth $622k and 0 open-market sells worth $0, the latest filed on Mar 3, 2026.
A track record needs three past buys with six months of prices behind them; Laith L Yaldoo has 1, so none is measured yet.
The newest scored trade: bought $15k of ZIVO on Feb 27, 2026, filed Mar 3, 2026, scored 23 (weak). In the last 12 months: 5 buys worth $100k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZIVO: Zivo Bioscience, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | ZIVObuy Zivo Bioscience, Inc. | $15k 1,543 shares | +0% | +35% from low-55% from high | |
| 31Weak | Zivo Bioscience, Inc. | $25k 2,434 shares | +0% | +45% from low-53% from high | |
| 38Weak | Zivo Bioscience, Inc. | $15k 1,766 shares | +0% | +29% from low-58% from high | |
| 23Weak | ZIVObuy Zivo Bioscience, Inc. | $25k 2,777 shares | +0% | +49% from low-49% from high | |
| 38Weak | Zivo Bioscience, Inc. | $20k 1,659 shares | +0% | +32% from low-40% from high | |
| 47Moderate | Zivo Bioscience, Inc. | $245k 15,322 shares | +3% | +60% from low-28% from high | |
| 25Weak | ZIVObuy Zivo Bioscience, Inc. | $50k 3,488 shares | +1% | +17% from low-37% from high | |
| 31Weak | ZIVObuy Zivo Bioscience, Inc. | $177k 10,080 shares | +2% | +46% from low-21% from high | |
| 25Weak | Zivo Bioscience, Inc. | $50k 3,133 shares | +1% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: HEP Investment, LLC | +1,543 | $9.72 | $15k | 583,615 | Mar 3, 2026 |
| Feb 10, 2026 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: HEP Investments LLC | +2,434 | $10.27 | $25k | 582,072 | Feb 12, 2026 |
| Jan 14, 2026 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +1,766 | $8.49 | $15k | 579,638 | Jan 27, 2026 |
| Nov 28, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +2,777 | $9.00 | $25k | 577,872 | Dec 2, 2025 |
| Oct 10, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +1,659 | $12.05 | $20k | 575,095 | Oct 14, 2025 |
| Oct 2, 2025 | ZIVO Zivo Bioscience, Inc. | AGrant or award Nonstatutory Stock Options to buy Common Stockderivative | +926 | $10.20 | $9,445 | 926 | Oct 6, 2025 |
| Sep 30, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +15,322 | $15.99 | $245k | 573,436 | Oct 2, 2025 |
| Jun 13, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: By HEP Investments LLC | +3,488 | $14.33 | $50k | 558,114 | Jun 16, 2025 |
| Jun 13, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Warrant for Common Stockderivativeindirect: By HEP Investments LLC | +348 | $14.33 | $4,987 | 348 | Jun 16, 2025 |
| Jan 22, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: By HEP Investments LLC | +7,200 | $17.53 | $126k | 551,746 | Apr 4, 2025 |
| Jan 22, 2025 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: By HEP Investments LLC | +2,880 | $17.53 | $50k | 554,626 | Apr 4, 2025 |
| Oct 16, 2024 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stockindirect: By entity | +3,133 | $15.96 | $50k | 533,424 | Oct 17, 2024 |
| Oct 16, 2024 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivativeindirect: By entity | +313 | $15.96 | $4,995 | 313 | Oct 17, 2024 |
Questions about Laith L Yaldoo
Answered from the filings on this page, as of the latest one.
Is Laith L Yaldoo buying or selling?
In the last 12 months Laith L Yaldoo reported 5 open-market buys worth $100k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $15k of ZIVO on Feb 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Laith L Yaldoo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Laith L Yaldoo has 1.
Where does Laith L Yaldoo file Form 4?
Laith L Yaldoo has filed Form 4 at ZIVO (Zivo Bioscience, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.